The presence of a sublethal amount of apramycin, the aminoglycoside antibiotic used as a selectable marker in transformations of Saccharopolyspora erythraea with pKC505 and related plasmids, was found to suppress phenotypically the S. erythraea eryB25 and eryB26 mutations blocking erythromycin biosynthesis in this organism, probably by the effect of mistranslation.
Genetic analysis of antibiotic production has commonly depended on the isolation of mutants that accumulate an intermediate in antibiotic formation, followed by the search for a segment of DNA that, when cloned into such strains, restores antibiotic production by apparent complementation of the pathway-specific mutation (3) . For the cloning and analysis of the genes (ery genes) governing the production of erythromycin, a 14-membered macrolide antibiotic of Saccharopolyspora erythraea, this approach has been hampered by the instability of transformants obtained with many of the available cloning vectors (10) .
We have discovered a further complication with the use of this method: restoration of antibiotic production by apparent phenotypic suppression of the S. erythraea eryB25 and eryB26 mutations with apramycin. This finding invalidates our recently published conclusion that these two mutations map upstream of the ermE gene (10) and suggests that the complementation of the S. erythraea eryB25 mutation reported earlier by Eli Lilly researchers was due to the same effect (9) .
Since antibiotic production had been restored by transformation of either of the eryB25 and eryB26 mutants with a 7-kb BamHI DNA segment approximately 14 kb upstream of ermE (10) , we transformed the eryB25 and eryB26 strains with pKC505 (8) subclones of the adjacent 3-and 4-kb BamHI DNA fragments within this segment and found that both fragments restored antibiotic production in 100o of the approximately 60 apramycin-resistant (Apmr) colonies assayed in each experiment. Since we have no reason to believe that these two strains contain allelic mutations, the fact that nonoverlapping DNA segments could apparently complement the same mutations was surprising. Further experiments with BamHI DNA segments from other locations in the ery cluster near ermE (10) and with two other cosmid clones randomly chosen from the library of S. erythraea DNA (10) came to the same end: all of the approximately 60 Apmr transformants tested in each experiment were Ery+. The observation that transformation of the two eryB mutants with a pKC505 clone containing DNA from Streptomyces peucetius (6) also restored antibiotic production finally showed that something unexpected was happening.
To determine which antibiotic was produced in these experiments, we grew representative transformants in liquid R2T medium containing 20 ,ug of apramycin (APM) per ml, extracted the cultures with ethyl acetate, and separated the * Corresponding author.
metabolites by thin-layer chromatography as described by Vara et al. (10) . Bioautography with Micrococcus luteus (erythromycin-sensitive, Apm), a thiostrepton-resistant strain of Staphylococcus aureus (erythromycin-sensitive, Apms), and S. aureus BW37 (erythromycin-resistant, Apms) revealed zones of growth inhibition of the M. luteus and S. aureus strains only at the locations corresponding to the erythromycin A standard in the extracts of wild-type S. erythraea and all of the Ery+ transformants tested. No zones were seen with the S. aureus BW37 strain, which is resistant to 500 ,ug of erythromycin A per ml. Thus, the transformants produced an antibiotic that most likely was erythromycin A or one of its biologically active precursors (10, 11) that was not resolved from erythromycin A on the chromatograms.
We tested representative transformants that were able to be serially transferred on R2T containing 20 pLg of APM per ml for the presence of plasmid DNA because few of the available plasmid vectors stably transform S. erythraea (10) . Evidence for the presence of pKC505 or related plasmids was not obtained by direct isolation from S. erythraea, by rescue of the isolated plasmid DNA in Escherichia coli, or by Southern analysis of total DNA obtained from the transformants after its digestion with BamHI, EcoRI, or PstI, blot-transfer, and probing with BamHI-digested, 32P-labeled pKC505. It thus appears that pKC505 and related plasmids can confer phenotypic but not genotypic Apmr to S. erythraea transformants, because the nontransformed strains did not grow in R2T broth under the same conditions.
Although we had not seen Ery+ transformants in the original control experiment for unknown reasons (10) , upon careful repetition of this experiment several times Ery+ colonies could be seen when S. erythraea (pKC505) transformants were assayed for antibiotic activity by the agar plug method (11) . To determine whether some portion of pKC505 was responsible for this result, we treated Xbal-digested pKC505 with exonuclease III as described by Henikoff (2) and characterized the resulting deletions by restriction mapping of the plasmid DNA isolated from E. coli. The eryB26 mutant was transformed with seven of these plasmids, and when 10 of the resulting Apmr colonies from each transformation were assayed, 20 luteus, which is resistant to 100 ,ug of APM per ml (Fig. 1A) .
APM did not restore antibiotic production to the S. erythraea eryB40 mutant (or to the eryB46 and eryB63 mutants [10, 11] (Fig. 1B) .
We conclude from these data that the restoration of erythromycin production by the S. erythraea eryB25 and eryB26 mutants is due to phenotypic suppression of these two mutations by APM and not to their complementation in trans or to some type of gene repair process. This belief is supported by the fact that APM can suppress amber arg and lac mutations in E. coli (J. E. Davies, personal communication) and cause mistranslation in cell-free systems from E. coli programmed with poly(U) templates (7) . (Confirmation that the same effect actually occurs in S. erythraea must await mapping and sequencing of the eryB25 and eryB26 loci to see whether these are nonsense mutations.) We are unaware of a prior report of this phenomenon in other studies of the genetics of actinomycetes. It may be encountered, however, because mistranslation effects are known for other aminoglycosides (1) whose resistance genes can be used as selectable markers (4) . This possibility underscores the need for appropriate controls when genetically uncharacterized mutations are being studied.
